Organovo Holdings, Inc. 4OR1.F Stock
Organovo Holdings, Inc. Price Chart
Organovo Holdings, Inc. 4OR1.F Financial and Trading Overview
| Organovo Holdings, Inc. stock price | 0.91 EUR |
| Previous Close | 1.77 EUR |
| Open | 1.63 EUR |
| Bid | 1.63 EUR x N/A |
| Ask | 1.68 EUR x N/A |
| Day's Range | 1.63 - 1.63 EUR |
| 52 Week Range | 1.28 - 3.52 EUR |
| Volume | 200 EUR |
| Avg. Volume | 33 EUR |
| Market Cap | 14.87M EUR |
| Beta (5Y Monthly) | 0.845774 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.01 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
4OR1.F Valuation Measures
| Enterprise Value | -3911271 EUR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 8.703593 |
| Price/Book (mrq) | 0.63565284 |
| Enterprise Value/Revenue | -2.29 |
| Enterprise Value/EBITDA | 0.338 |
Trading Information
Organovo Holdings, Inc. Stock Price History
| Beta (5Y Monthly) | 0.845774 |
| 52-Week Change | -3.19% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 3.52 EUR |
| 52 Week Low | 1.28 EUR |
| 50-Day Moving Average | 1.77 EUR |
| 200-Day Moving Average | 1.81 EUR |
4OR1.F Share Statistics
| Avg. Volume (3 month) | 33 EUR |
| Avg. Daily Volume (10-Days) | 11 EUR |
| Shares Outstanding | 8.71M |
| Float | 8.64M |
| Short Ratio | N/A |
| % Held by Insiders | 0.98% |
| % Held by Institutions | 13.90% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:20 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | March 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | March 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -694.67% |
| Gross Margin | -167.62% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -24.64% |
| Return on Equity (ttm) | -43.71% |
Income Statement
| Revenue (ttm) | 1.71M EUR |
| Revenue Per Share (ttm) | 0.2 EUR |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | -1820000 EUR |
| EBITDA | -11585000 EUR |
| Net Income Avi to Common (ttm) | -11711000 EUR |
| Diluted EPS (ttm) | -1.33 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 20.75M EUR |
| Total Cash Per Share (mrq) | 2.38 EUR |
| Total Debt (mrq) | 1.9M EUR |
| Total Debt/Equity (mrq) | 8.53 EUR |
| Current Ratio (mrq) | 15.708 |
| Book Value Per Share (mrq) | 2.558 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -9216000 EUR |
| Levered Free Cash Flow (ttm) | -5323625 EUR |
Profile of Organovo Holdings, Inc.
| Country | Germany |
| State | CA |
| City | Solana Beach |
| Address | 11555 Sorrento Valley Road |
| ZIP | 92121 |
| Phone | 858 224 1000 |
| Website | https://www.organovo.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 9 |
Organovo Holdings, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised mammalian cells; and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. The company offers ExVive human liver tissue and ExVive human kidney tissue used for predictive preclinical testing of drug compounds. The company was incorporated in 2007 and is headquartered in Solana Beach, California.
Q&A For Organovo Holdings, Inc. Stock
What is a current 4OR1.F stock price?
Organovo Holdings, Inc. 4OR1.F stock price today per share is 0.91 EUR.
How to purchase Organovo Holdings, Inc. stock?
You can buy 4OR1.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Organovo Holdings, Inc.?
The stock symbol or ticker of Organovo Holdings, Inc. is 4OR1.F.
Which industry does the Organovo Holdings, Inc. company belong to?
The Organovo Holdings, Inc. industry is Biotechnology.
How many shares does Organovo Holdings, Inc. have in circulation?
The max supply of Organovo Holdings, Inc. shares is 10.34M.
What is Organovo Holdings, Inc. Price to Earnings Ratio (PE Ratio)?
Organovo Holdings, Inc. PE Ratio is now.
What was Organovo Holdings, Inc. earnings per share over the trailing 12 months (TTM)?
Organovo Holdings, Inc. EPS is -2.01 EUR over the trailing 12 months.
Which sector does the Organovo Holdings, Inc. company belong to?
The Organovo Holdings, Inc. sector is Healthcare.